Simoa® for Cytokine Profiling and Antibody Detection in COVID-19 Research

The ability to differentiate elevated cytokine and chemokine levels, such as IL-6, IL-1b, IL-10, IL-8, and TNFα, from healthy baseline with the highest level of precision is critical to SARS-Cov-2 research. The Simoa SP-X Imaging and Analysis System is accelerating research efforts with the cost-effective solution for monitoring these targets with sensitivity and precision!

Now available on our HD-X platform, we are proud to introduce the ultra-sensitive Simoa Semi-Quantitative SARS-CoV-2 IgG Antibody assay. Our assay targets antibodies directed against the viral spike protein and provides a numerical result representing the concentration of antibodies from 0.21 to 250 mg/mL. Learn more about its application by downloading the recently published app note.

SP-X Imaging and Analysis System

The Quanterix SP-X Imaging and Analysis System is a complete benchtop system that offers true multiplex detection at both acute and baseline levels.

get more information

Th1/Th2 customizable panel with up to 10 critical markers for cytokine profiling and COVID-19 induced cytokine storm

Plasma & SerumIFNyIL-1βIL-4IL-5IL-6IL-8IL-10IL-12p70IL-22TNFα
LLOD %80%85%43%100%100%100%100%58%100%100%
LLOQ %68%28%30%68%100%98%100%13%100%100%

Chemokine panel for cytokine storm

Above LLOQ %IP-10ITACMCP-1MIP-3b
Plasma100%100%58%100%
Serum100%68%13%100%

Angiogenesis panel monitoring and predicting vascular disease associated with COVID-19

Above LLOQ %ANG-2HB-EGFVEGF-CPlGFFGFbHGFVEGF
Plasma100%100%83%100%0%92%100%
Serum100%100%100%100%0%92%100%

Does your research focus on neuropathy associated with SARS-Cov-2 infection?

Check out the extensive neurology menu on HD-X and SR-X providing the same level of sensitivity and precision as SP-X for your cytokine research